Venture Capital

VENTURE CAPITAL

Bridging innovation and growth

Venture Capital

With over 40 years of experience and over $845 million invested across various funds, First Analysis is a leading venture capital investor in B2B tech companies. Primarily investing in North America, we target entrepreneur-driven, capital-efficient companies with proven business models and demonstrable customer successes. We partner with our portfolio companies to build for successful exits in every investment we undertake. We invest $3 to $10 million, either as a lead investor or as a syndicate partner bringing valuable insights and expertise in our focus sectors.

+
years of insights, relationships and experience
$million+
invested
funds
$3-$10 million
initial investment
+
investments
$1-$10 million
target ARR for B2B tech companies

Select portfolio companies

Healthcare ITInternet of things (IoT)
Intelligent Locations

Intelligent Locations

intelligentlocations.ioLearn more
Intelligent Locations

Intelligent Locations pioneered the development of INTRAXтДв, delivering an advanced AI-powered localization platform for healthcare enterprises. Its software provides healthcare professionals with intuitive tools to track, measure and analyze assets, staff safety, patient satisfaction, operational workflows, environmental conditions and more. Headquartered in RaleighтАЩs Research Triangle, with a Center of Excellence in Paris, the company continuously advances its predictive analytics and machine learning capabilities.

Learn more
Cybersecurity
Gradient Cyber

Gradient Cyber

gradientcyber.comLearn more
Gradient Cyber

Gradient Cyber is a fast-growing managed extended detection and response (MXDR) provider serving the U.S. mid-market тАУ an underserved segment of over 300,000 organizations. The companyтАЩs proprietary XDR platform, data source flexibility, 24/7 security operations center, high-context situation reports (SitReps) and industry-leading cyber analyst to customer ratio combine to deliver excellent value for resource, expertise and budget-constrained organizations. With proven traction across 35+ market verticals, Gradient Cyber is well positioned to scale even as cybersecurity becomes increasingly complex and talent constrained.

Learn more
Pharma IT
Applied StemCell

Applied StemCell

www.appliedstemcell.comLearn more
Applied StemCell

Applied StemCell is a leading CRO/CDMO specializing in cell and gene therapy. Leveraging its proprietary TARGATT genome editing and iPSC platform, the company is dedicated to supporting clients in research, preclinical development, and clinical manufacturing for novel therapeutics. ASC is committed to offering a platform enabling significant cost reductions in cell drug development, delivering ready-to-use cell medicine, and, most importantly, saving human lives.

Learn more
Pharma IT
Sware

Sware

www.sware.comLearn more
Sware

Sware’s mission is to rescue life sciences companies from the grip of validation debt; the unpaid cost of release, testing, GxP, and business requirements. The Res_Q software platform offers a complete validation solution. Res_Q eliminates validation debt and ensures peace of mind in an increasingly complex technology ecosystem.

Learn more
Healthcare IT
Dina212202411386

Dina

www.dinacare.comLearn more
Dina212202411386

Dina provides digital network management and coordination solutions to help health plans and providers improve access to in-home care, long-term services and supports, and supplemental benefits. Customers use DinaтАЩs platform to digitize their provider networks, transform coordination workflows, manage compliance reporting requirements, and collect valuable insights from the home and community. As a result, coordinators can spend more time helping people stay home safely and less time with phone calls, emails and faxes. The Dina platform has earned certified status by HITRUST for information security. In 2022, Dina was named to the Inc. 5000 list of fastest-growing companies, and CB Insights Digital Health 150 list of companies transforming healthcare with digital technology.

Learn more
Healthcare IT
Kno2

Kno2

kno2.comLearn more
Kno2

Kno2 provides a communication platform that enables secure patient information exchange between healthcare providers, payers and patients. Traditional point-to-point healthcare data exchange systems omit many parties in care chains, increasing healthcare costs and hurting patient experience and outcomes, so healthcare stakeholders are under intense pressure to improve patient data exchange. Kno2’s unique platform, delivered via a channel-partner go-to-market strategy, solves this problem with a network that connects all parties.

Cybersecurity
Stamus Networks

Stamus Networks

stamus-networks.comLearn more
Stamus Networks

Stamus Networks believes in a world where defenders are heroes, and a future where those they protect remain safe. As organizations face threats from well-funded adversaries, Stamus relentlessly pursues solutions that make the defenderтАЩs job easier and more impactful. As a leader in Suricata-based network security solutions, Stamus Networks helps enterprise security teams know more, respond sooner and mitigate their risk with insights gathered from cloud and on-premise network activity. The Stamus Security Platform combines the best of intrusion detection, network security monitoring, and network detection and response systems into a single solution that exposes serious and imminent threats to critical assets and empowers rapid response.

Learn more
Pharma IT
Yunu(1) Gfx 29092022085520

Yunu

www.yunu.ioLearn more
Yunu(1) Gfx 29092022085520

Yunu provides medical research technology and services to life sciences companies and clinical research environments that perform precision imaging assessments. YunuтАЩs aim is to ensure breakthrough therapies are accessible to everyone by unifying medical imaging insights and connecting clinical communities. With thousands of clinical trials relying on the platform each day, Yunu is delivering a new standard of oncology trial management.

Learn more

Latest venture capital news

Latest Venture Capital News
Venture capitalInvestment banking
Healthcare ITInternet of things (IoT)
Intelligent Locations

First Analysis advised, invested in healthcare tech provider Intelligent Locations

First Analysis Securities Corp. advised Intelligent Locations on its recent growth investment from Marlin Equity Partners. Intelligent Locations is a leading provider of AI-powered real-time location software for healthcare enterprises. Intelligent LocationsтАЩ suite of solutions enables hospitals to track assets, people and processes in real-time. Venture capital fund First Analysis Fund XIV also participated in the investment. The investment will support further advancement of Intelligent LocationsтАЩ AI-powered INTRAXTM platform to optimize critical business and clinical operations for hospitals.
Learn more: First Analysis advised, invested in healthcare tech provider Intelligent Locations Load More : First Analysis advised, invested in healthcare tech provider Intelligent Locations
Venture capital
Cybersecurity
Gradient Cyber News

First Analysis invests in Gradient Cyber, provider of MXDR services for mid-market organizations

First Analysis, a leading venture capital investor, has made a new investment in Gradient Cyber, a leading provider of managed extended detection and response (MXDR) services for mid-market organizations. First Analysis led the Series A financing, which will support Gradient Cyber’s continued growth and product development as it scales to meet increasing demand for 24/7 MXDR services.
Learn more: First Analysis invests in Gradient Cyber, provider of MXDR services for mid-market organizations Load More : First Analysis invests in Gradient Cyber, provider of MXDR services for mid-market organizations
Venture capital
Fa2025 Element

First Analysis closes on Fund XIV at $97 million in committed capital

First Analysis, a leading venture capital firm specializing in B2B technology investments, announced today the closing of its 14th fund, at $97 million in committed capital. First Analysis again committed substantial capital to its own fund, making it the largest investor in the new fund and underscoring its continued confidence in its distinctive investment approach.
Learn more: First Analysis closes on Fund XIV at $97 million in committed capital Load More : First Analysis closes on Fund XIV at $97 million in committed capital
Venture capital
Enterprise productivity
PCMI

First Analysis portfolio company PCMI receives strategic growth investment from Thoma Bravo

Thoma Bravo, a leading software investment firm, has made a strategic growth investment in PCMI, a portfolio company of First Analysis and Equality Asset Management. PCMI is a leading provider of administration software for finance and insurance products in the automotive and consumer end markets. Thoma BravoтАЩs expertise in scaling technology companies will help accelerate PCMIтАЩs global growth and support its efforts in enhancing the platform. William Blair acted as the exclusive financial advisor to PCMI.
Learn more: First Analysis portfolio company PCMI receives strategic growth investment from Thoma Bravo Load More : First Analysis portfolio company PCMI receives strategic growth investment from Thoma Bravo
Venture capital
Enterprise productivityFuture of work
Amplifund

First Analysis portfolio company AmpliFund has been acquired by Euna Solutions

Euna Solutions, a provider of SaaS solutions purpose-built for the public sector, has acquired First Analysis portfolio company AmpliFund, a leading grant management platform provider. This strategic move enhances Euna SolutionsтАЩ existing grant management product suite, further solidifying its commitment to delivering innovative and comprehensive tools for government agencies, nonprofits and other public sector organizations.
Learn more: First Analysis portfolio company AmpliFund has been acquired by Euna Solutions Load More : First Analysis portfolio company AmpliFund has been acquired by Euna Solutions